In contrast, mTORC1 activation was significantly correlated with enhanced glutaminase activity and decreased GCN5L1 expression in HCC, further supporting that GCN5L1 could modulate the mTORC1 pathway via the regulation of acetylation and GLS1 and GLS2 activity to control HCC development. The gene discussed is GLS2; the disease is hepatocellular carcinoma.